)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Insight Molecular Diagnostics
Insight Molecular Diagnostics (IMDX) investor relations material
Insight Molecular Diagnostics KOL event summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.KOL event summary17 Aug, 2026
Introduction and agenda
The session focused on advances in donor-derived cell-free DNA (dd-cfDNA) testing for heart transplant surveillance, featuring a fireside chat and Q&A with a leading transplant cardiologist.
Discussion included the evolution of transplant monitoring, current protocols, and the potential impact of new in-house dd-cfDNA assays.
KOL background and credentials
Dr. Max Liebo, a transplant cardiologist at Loyola University, has over a decade of experience using molecular surveillance in heart transplant patients.
He has participated in major registries and has experience with multiple dd-cfDNA products.
Market insights and analysis
Heart transplant rejection surveillance has shifted from frequent invasive biopsies to non-invasive molecular assays over the past decade.
Recent guidelines and literature increasingly support dd-cfDNA as a primary tool for rejection monitoring.
Adoption barriers include logistical challenges, inertia in protocol updates, and the need for more real-world data.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Insight Molecular Diagnostics
- Innovative transplant monitoring kits drive decentralized diagnostics in a $3B global market.IMDX
Investor presentation - FDA review advances, Medicare expands coverage, and Q2 loss narrows on cost discipline.IMDXQ2 2026
- Minimal Q1 revenue as focus shifts to FDA approval and commercialization of transplant assay.IMDXQ1 2026
- Decentralized diagnostic kits and strong partnerships drive growth in transplant monitoring.IMDXInvestor presentation
- Virtual meeting to elect directors, ratify auditor, approve pay, and expand equity plan.IMDXProxy filing
- Proxy covers director elections, auditor ratification, compensation, and equity plan expansion.IMDXProxy filing
- GraftAssure's decentralized PCR test drives transplant diagnostics innovation and market expansion.IMDX25th Annual Needham Virtual Healthcare Conference
- Patent-protected transplant test nears FDA submission, targeting rapid, high-margin adoption.IMDXH.C. Wainwright 27th Annual Global Investment Conference
- GraftAssure's launch, Bio-Rad deal, and capital raise set the stage for future high-margin growth.IMDXQ2 2024
Next Insight Molecular Diagnostics earnings date
Q3 20269 Nov, 2026
Insight Molecular Diagnostics
Next Insight Molecular Diagnostics earnings date
Q3 20269 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage